Clinical Trials on Non-Hodgkin's Lymphoma in Australia
Total 1218 results
-
Austin HealthMerck KGaA, Darmstadt, GermanyActive, not recruitingLymphomas Non-Hodgkin's B-CellAustralia
-
CelgeneTerminatedT-cell Non-Hodgkin's LymphomaFrance, United States, Australia, Belgium
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseAustralia
-
Arbeitsgemeinschaft medikamentoese TumortherapieMerck Sharp & Dohme LLC; Celgene CorporationTerminatedPeripheral T-Cell Non-Hodgkin's LymphomaAustria
-
Caribou Biosciences, Inc.RecruitingLymphoma | Lymphoma, Non-Hodgkin | B Cell Lymphoma | Non Hodgkin Lymphoma | Refractory B-Cell Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | B Cell Non-Hodgkin's LymphomaUnited States, Australia, Israel
-
IGM Biosciences, Inc.No longer availableRelapsed/Refractory Non-Hodgkin LymphomasAustralia, Korea, Republic of, Spain
-
Innate PharmaRecruitingNon Hodgkin LymphomaUnited States, Australia
-
Rhizen Pharmaceuticals SACompletedNon Hodgkin LymphomaUnited States, Australia
-
Antengene Biologics LimitedRecruitingAdvanced Solid Tumor | Metastatic Solid Tumor | Mature B-cell Non-Hodgkin LymphomaUnited States, Australia
-
Gilead SciencesThe Leukemia and Lymphoma SocietyActive, not recruitingNon Hodgkin LymphomaUnited States, Australia, United Kingdom
-
Iksuda Therapeutics Ltd.RecruitingFollicular Lymphoma | B-cell Lymphoma | Mantle Cell Lymphoma | Diffuse Large B Cell Lymphoma | B-cell Non-Hodgkin LymphomaAustralia, Canada, United States
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Canada, Spain, Taiwan, France, Australia, United Kingdom, Poland, Italy, Israel, Czechia, Germany, Russian Federation, Sweden
-
Gilead SciencesTerminatedIndolent Non-Hodgkin's LymphomasUnited States, Korea, Republic of, Hungary, United Kingdom, Australia, Singapore, Japan, Taiwan, Israel, Italy, Spain, Czechia, Russian Federation, France, Poland, Romania, Germany, Portugal, Sweden
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaSpain, France, United Kingdom, Germany, Australia, Italy
-
AstraZenecaTerminatedNon-Hodgkin LymphomaSpain, United States, Korea, Republic of, France, Portugal, Australia, Italy
-
AbbVieGenentech, Inc.CompletedChronic Lymphocytic Leukemia | Non-Hodgkin LymphomaUnited States, Australia
-
BeiGeneActive, not recruitingRelapsed/Refractory Follicular Non-Hodgkin LymphomaKorea, Republic of, New Zealand, United States, China, Taiwan, Spain, Italy, Australia, Canada, United Kingdom, Belarus, Bulgaria, Czechia, France, Germany, Poland, Russian Federation
-
Hoffmann-La RocheCompletedNon-Hodgkin's LymphomaFrance, Italy, Australia, Canada, Sweden, Switzerland
-
Eli Lilly and CompanyCompletedT-Cell Lymphoma | B-Cell LymphomaMexico, United States, Australia, Brazil, Peru
-
Hoffmann-La RocheCompletedNon-Hodgkin Lymphoma, Follicular LymphomaUnited Kingdom, Belgium, United States, Australia, Canada, Germany
-
Murdoch Childrens Research InstituteNot yet recruitingHodgkin Lymphoma | Non Hodgkin LymphomaAustralia
-
Bayside HealthCompletedNon-Hodgkin's Lymphoma | Hodgkin's DiseaseAustralia
-
AbbVieGenentech, Inc.Active, not recruitingNon-Hodgkin's Lymphoma | Hematological Malignancies | Chronic Lymphoid Leukemia | CD20-Positive Lymphoid MalignanciesUnited States, Australia
-
K-Group Alpha, Inc., a wholly owned subsidiary...RecruitingAcute Myeloid Leukemia | Non Hodgkin LymphomaCroatia, Australia, Bulgaria, Korea, Republic of, Ukraine, Poland, Spain
-
Hoffmann-La RocheAbbVieCompletedFollicular LymphomaUnited States, Italy, Canada, Australia, Belgium, United Kingdom, Germany, France
-
Mundipharma Research LimitedInnovative Therapies For Children with Cancer ConsortiumTerminatedRelapsed or Refractory T-cell Acute Lymphoblastic Leukaemia | B-cell Precursor Acute Lymphoblastic Leukaemia | T-cell Non-Hodgkin's LymphomaCzech Republic, Austria, France, Germany, Italy, United Kingdom
-
Hoffmann-La RocheRecruitingNon-Hodgkin's LymphomaBelgium, Australia, Denmark, Spain, Taiwan, France, Italy, United States, Canada, Czechia, New Zealand, Poland, Finland
-
Hoffmann-La RocheCompletedDiffuse Large B-Cell Lymphoma, Non-Hodgkin's LymphomaHong Kong, Germany, Philippines, Taiwan, Turkey, Canada, Australia, Austria, New Zealand, Thailand, Hungary, Italy, Korea, Republic of, Romania, Netherlands, Brazil, Indonesia, Croatia, Egypt, Portugal, Sweden, Colombia, Argentina, De... and more
-
AmgenCompletedB-Cell Non Hodgkin LymphomaUnited States, Spain, United Kingdom, Belgium, Italy, Australia, Canada, Puerto Rico
-
PfizerCompletedHodgkin Disease | Thrombocytopenia | Non-Hodgkin LymphomaUnited States, Russian Federation, Singapore, Australia, France, Hong Kong, Greece, Poland
-
IGM Biosciences, Inc.ADC Therapeutics S.A.Active, not recruitingFollicular Lymphoma | Mantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | DLBCLUnited States, Korea, Republic of, Spain, France, Australia, Czechia, Italy
-
Mundipharma Research LimitedTerminatedIndolent B-cell NHLAustralia, Slovakia
-
Nordic NanovectorICON Clinical ResearchActive, not recruitingFollicular Lymphoma | Non-Hodgkin LymphomaUnited States, Korea, Republic of, Australia, Austria, Belgium, Canada, Croatia, Czechia, Denmark, Finland, France, Hungary, Ireland, Israel, Italy, Netherlands, Norway, Poland, Singapore, Spain, Sweden, Switzerland, Turkey, United Kingdom
-
Hoffmann-La RocheCompletedB-cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Austria, Poland
-
Novartis PharmaceuticalsXOMA (US) LLCCompletedHodgkin's Lymphoma | Non-Hodgkin's LymphomaUnited States, Belgium, Canada, Italy, France, Hong Kong, Australia, United Kingdom, Singapore, Korea, Republic of, Germany
-
Dizal PharmaceuticalsNot yet recruitingLymphoma, Non-HodgkinAustralia
-
CephalonCompletedNon-Hodgkin's Lymphoma | Mantle Cell LymphomaAustralia, Canada, United States
-
BeiGeneRecruitingRefractory Chronic Lymphocytic Leukemia | Refractory Non-Hodgkin Lymphoma | Relapsed Follicular Lymphoma | Refractory Small Lymphocytic Lymphoma | Refractory Follicular Lymphoma | Refractory Marginal Zone Lymphoma | Refractory Diffuse Large B-cell Lymphoma | Transformed Non-Hodgkin Lymphoma | Relapsed... and other conditionsChina, Australia
-
Millennium Pharmaceuticals, Inc.Johnson & Johnson Pharmaceutical Research & Development, L.L.C.CompletedStudy of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's LymphomaNon-Hodgkin's LymphomaFrance, United States, Spain, Korea, Republic of, Australia, Israel, India, Thailand, China, Czech Republic, Belgium, New Zealand, Russian Federation, Finland, South Africa, United Kingdom, Italy, Brazil, Hungary, Puerto Rico, A... and more
-
PfizerCompletedNon-Hodgkin's LymphomaKorea, Republic of, Australia, Czechia, United States, Romania, Germany, France, Poland, Italy, Russian Federation, Serbia
-
Melbourne HealthRecruitingMyelodysplastic Syndromes | Leukemia, Myeloid, Acute | Plasma Cell Myeloma | Non-hodgkin Lymphoma | Leukemia, Lymphoblastic, Acute, L1 | Leukemia, Lymphoblastic, Acute, L2Australia
-
GenmabRecruitingNon-Hodgkin Lymphoma | Classical Hodgkin LymphomaUnited States, Australia
-
CelgeneActive, not recruitingLymphoma, Non-HodgkinUnited States, Italy, Austria, Canada, France, Germany, Japan, Spain, Sweden, United Kingdom
-
AmgenCompletedNon-Hodgkin's LymphomaUnited States, Australia, Italy, United Kingdom, Germany, France
-
Hoffmann-La RocheRecruitingMature B-Cell Non-Hodgkin LymphomaUnited States, Spain, Korea, Republic of, France, Denmark, Australia, Germany, Italy
-
Children's Oncology GroupNational Cancer Institute (NCI)CompletedMantle Cell Lymphoma | Marginal Zone Lymphoma | Non-Hodgkin Lymphoma | Small Lymphocytic Lymphoma | Lymphoproliferative Disorder | Primary Cutaneous B-Cell Non-Hodgkin Lymphoma | Grade 1 Follicular Lymphoma | Grade 2 Follicular Lymphoma | Primary Cutaneous T-Cell Non-Hodgkin Lymphoma | Grade 3 Follicular... and other conditionsUnited States, Canada, Australia, Puerto Rico
-
Hoffmann-La RocheTerminatedNon-Hodgkin's LymphomaUnited States, Australia, Korea, Republic of, Germany, New Zealand
-
Janssen Research & Development, LLCCity of Hope Medical CenterRecruitingRelapsed or Refractory B Cell Non-Hodgkin LymphomaUnited States, Australia
-
Institut de Recherches Internationales ServierADIR, a Servier Group companyCompletedChronic Lymphocytic Leukaemia (CLL) | Multiple Myeloma (MM) | B-Cell Non-Hodgkin Lymphoma (NHL)France, Australia, Germany, Korea, Republic of, United Kingdom, Hungary, Poland, Singapore
-
Incyte CorporationActive, not recruitingChronic Lymphocytic Leukemia | Non Hodgkin LymphomaUnited States, Spain, France, Italy, Belgium, Germany, Austria